Genomic Health

Genomic Health is a biotechnology company that provides genomic-based diagnostic tests aimed at addressing overtreatment and optimal treatment of early-stage cancer. It is a provider of cancer screening and genomic-based diagnostic tests and molecular diagnostics tests for patients with cancer and liquid biopsy.

Genomic Health is a California-based provider of genomic-based diagnostic tests that focuses on the development and global commercialization of genomic-based clinical laboratory services. Founded 2000 in Redwood City, California, United States, it invests in series E, series D and series F rounds. Its portfolio companies include Epic Sciences and Invitae. As of February 2020, Genomic Health has made four investments. Their most recent investment was on September 12, 2018, when Epic Sciences raised $52M. Genomic Health has had one exit, which was Invitae. Invitae is a company that reinvents genetic testing by lowering the barriers for clinicians and patients to obtain diagnostic genetic information.